Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Friday, July 12, 2013

Lenalidomide (Revlimid) Meets Primary Endpoint in Myeloma Study

A phase III study of lenalidomide in combination with dexamethasone in patients newly diagnosed with multiple myeloma has met its primary endpoint of progression-free survival .

http://www.formkit.com/news/DailyDetail.cfm?chosen=67570
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts